News

Compared to the firm's previous PGx offering, the new service is somewhat smaller in terms of content and better supported by ...
The scientists said that the test could help clinicians overcome a lack of specificity in prostate-specific antigen tests and ...
The US Food and Drug Administration issued marketing clearances for antimicrobial susceptibility tests, respiratory infection tests, and a cardiac troponin test, among others.
Titled the RESULTS Act, the bill would use third-party private-payor data to set Medicare lab payment rates, addressing a ...
The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.
The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.
According to the government, the defendants operated an illegal kickback scheme in which True Health Diagnostics paid doctors kickbacks for test referrals.
The study will use the BioFire SpotFire system in its assessment of a direct-acting antiviral medicine to treat rhinovirus in patients with COPD.
NEW YORK – Siemens Healthineers and Evident said Wednesday that they are partnering on the delivery of a digital pathology workflow to the German nonprofit teaching hospital Klinikum der Stadt ...
NEW YORK – Lucid Diagnostics said on Thursday it has closed its public offering of its common stock, raising about $26.9 million in net proceeds.
Last week, readers were most interested in a story about Foresight and Roche reaching a technology licensing deal after ending their patent dispute.